KYTHERA BIOPHARMACEUTICALS INC

CALABASAS, CA How do I update this listing?

Kythera Biopharmaceuticals is based out of Calabasas. KYTHERA Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market. Its product candidate, ATX-101, is an injectable drug in Phase III clinical development for the reduction of submental fat. The company also has various additional research programs around therapeutic intervention for hair loss; and maintains active research interest in hair and fat biology, pigmentation modulation, and facial contouring.Whalewisdom has at least 111 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2011-09-15. The notice included securities offered of Equity,Other

Create Alert

Contact Info

kythera biopharmaceuticals inc
27200 WEST AGOURA ROAD
CALABASAS CA    91301

Business Phone: 818-587-4500
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2011-09-15 D PHARMACEUTICALS Equity,Other 52,424,997 37,424,989 15,000,008
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
CAMILLE SAMUELS subscription required
    DIRECTOR
DAVID SCHNELL subscription required
    DIRECTOR
DENNIS FENTON subscription required
    DIRECTOR
FRANCOIS KRESS subscription required
    DIRECTOR
HIRONORI HOZOJI subscription required
    DIRECTOR
JOHN SMITHER subscription required
    EXECUTIVE OFFICER
JOSEPH TURNER subscription required
    DIRECTOR
KEITH KLEIN subscription required
    EXECUTIVE OFFICER
KEITH LEONARD subscription required
    EXECUTIVE OFFICER DIRECTOR
NATHANIEL DAVID subscription required
    DIRECTOR
PATRICIA WALKER subscription required
    EXECUTIVE OFFICER
ROBERT NELSEN subscription required
    DIRECTOR

Elevate your investments